Tuesday, December 18, 2012

FDA finds more bacteria in New England Compounding drugs | Reduction

FDA finds more bacteria in New England Compounding drugs

mystery magic and medicine
mystery magic and medicine by FILTHFILLER dotcom
License (according to Flickr): Attribution License
Excerpt:

A sign requesting "No Soliciting" hangs on the door of New England Compounding in Framingham, Mass. An outbreak of a form of fungal meningitis is believed to have been traced back to the New England Compounding Center. (AP Photo/Stephan Savoia) U.S. health officials have found bacteria in lots of an injected steroid and a heart drug made by New England Compounding Center, the pharmacy linked to contaminated steroids that have claimed the lives of at least 28 people. The Food and Drug Administration said it identified different types of bacteria in three separate recalled batches of NECC's preservative-free betamethasone and in a single batch of NECC-supplied cardioplegia solution. Betamethasone is an injectable steroid, while cardioplegia is used during heart surgery.

FDA finds more bacteria in New England Compounding drugs

Additional Info:

Organization: Food and Drug Administration

Overall Sentiment: -0.207591

Relevance: 0.87048

Organization: New England Compounding Center.

Overall Sentiment: 0

Relevance: 0.660679

Organization: Centers for Disease Control and Prevention

Overall Sentiment: -0.186967

Relevance: 0.439823

StateOrCounty: Massachusetts

Overall Sentiment: 0.0140632

Relevance: 0.483716

Disambiguation: Location | PoliticalDistrict | AdministrativeDivision | GovernmentalJurisdiction | USStateReferences:

Country: U.S.

Overall Sentiment: 0.531535

Relevance: 0.364534

Disambiguation: Location | Region | AdministrativeDivision | GovernmentalJurisdiction | FilmEditorReferences:

Drug: betamethasone

Overall Sentiment: 0.125453

Relevance: 0.906454

Drug: methylprednisolone

Overall Sentiment: 0

Relevance: 0.3387

HealthCondition: meningitis

Overall Sentiment: -0.250172

Relevance: 0.811947

Header Info

No comments:

Post a Comment